Biopsy proportion of tumour predicts pathological tumour response and benefit from chemotherapy in resectable oesophageal carcinoma - results from the UK MRC OE02 trial

Matthew D. Hale, Matthew Nankivell, Gordon G. Hutchins, Sally P. Stenning, Ruth E. Langley, Wolfram Mueller, Nicholas P. West, Alexander I. Wright, Darren Treanor, Lindsay C. Hewitt, William H. Allum, David Cunningham, Jeremy D. Hayden, Heike I. Grabsch*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Biopsy proportion of tumour predicts pathological tumour response and benefit from chemotherapy in resectable oesophageal carcinoma - results from the UK MRC OE02 trial'. Together they form a unique fingerprint.

Keyphrases

INIS

Medicine and Dentistry